Expert end-to-end development and manufacturing of controlled substances. Our approach overcomes challenges with precision and confidence.
Our Unified Services Platform isn’t bespoke—it was purpose-designed and built from the ground up for the development, manufacturing, and distribution of controlled substances worldwide. Every stage is part of a seamless, end-to-end solution, enhanced by uncompromising quality control processes that ensure the highest standards are met. Each service works in harmony to deliver the precision, efficiency, and reliability you need to succeed.
Precision at the molecular level ensures all your compounds meet the highest industry standards as we deliver high-quality active ingredients tailored to your specifications.
LEARN MORE
Ensuring accuracy and compliance with testing and validation to guarantee total control of product quality, safety, and compliance. Every step is designed to support your success.
LEARN MORE
Our formulation development expertise transforms ideas into therapies through tailored, innovative solutions that optimize products for stability, efficacy, and patient safety.
LEARN MORE
From Concept to Scale, our manufacturing capabilities provide seamless scalability and consistent delivery. We produce with precision to ensure your product reaches the market with integrity and efficiency.
LEARN MORE
Our Regulatory Services team simplifies complex processes to help you navigate the intricate requirements of controlled substances, ensuring your product meets global standards while staying on schedule.
LEARN MORE
From Concept to Scale, our manufacturing capabilities provide seamless scalability and consistent delivery. We produce with precision to ensure your product reaches the market with integrity and efficiency.
Learn More
Discover how our Unified Services Platform brings together Formulation Development, Analytical Development, Stability Testing, Manufacturing, and Commercialization to streamline your drug development journey. Visit our Knowledge Center to access case studies, white papers, and expert insights that showcase the precision, efficiency, and innovation driving our platform.
Eric Kizior, Head of Commercial Pharmaceuticals, brings over 25 years of experience in the healthcare industry, specializing in commercial strategy, product launches, and business development. With leadership roles across public companies and private equity-backed startups, Eric has spearheaded over 20 product launches across 13 disease states, including Alzheimer’s, hypertension, oncology, and pain management.
Eric holds an undergraduate degree in Finance from Bradley University and has built his career around optimizing sales strategies, marketing operations, and field force effectiveness. His broad therapeutic expertise and proven ability to lead high-performing teams make him a trusted advisor in advancing innovative therapies to market.
Passionate about navigating complex markets, Eric is eager to answer your questions, discuss your commercialization needs, and explore how Benuvia’s expertise can help bring your products to market with precision and impact.
"*" indicates required fields
